zlacker

>>giulio+(OP)
>The share of U.S. households reporting at least one user rose from about 11% in late 2023 to more than 16% by mid-2024.

I was wondering how you could get such a high impact overall. But it seems one in 6 households are on GLP-1 drugs in the US.

In my friend circle in Germany I don't even know one single person on this stuff.

It's insane to me that so many people need these to get off the processed foods killing them in the US.

>>carlmr+B5
I was curious for a UK comparison so I looked it up.

At the start of 2025, about 3% of adults in UK had used GLP-1 drugs in past year in the UK. And "most GLP-1 for weight loss in the UK is from private, rather than NHS provision" [1].

[1] https://pmc.ncbi.nlm.nih.gov/articles/PMC12781702/

>>RobinL+4b
UK numbers are always interesting because the NHS leans conservative about access to many types of care and medication.

For another example, rates of COVID-19 vaccination are significantly lower in the UK not because people there don’t want vaccines, but because the NHS only makes them narrowly available to people above a certain age or with a strict set of conditions.